Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)
China flag China · Delayed Price · Currency is CNY
11.83
+0.19 (1.63%)
Feb 3, 2026, 3:04 PM CST

SHE:002728 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '20
Operating Revenue
923.16686.911,066886.15757.93632.22
Other Revenue
0.880.880.740.430.230.48
924.04687.791,067886.57758.16632.7
Revenue Growth (YoY)
18.84%-35.55%20.38%16.94%19.83%-31.31%
Cost of Revenue
405.72386.47467.98451.83356.12330.93
Gross Profit
518.32301.32599.23434.74402.04301.76
Selling, General & Admin
368.48225.54240.67176.38175.95153.87
Research & Development
39.7243.3343.0638.0137.7836.5
Other Operating Expenses
5.552.059.381.759.278.19
Operating Expenses
413.4270.89293.19216.74224.72197.63
Operating Income
104.9230.43306.04217.99177.33104.13
Interest Expense
-4.97-5.32-16.36-29.13-29.51-42.72
Interest & Investment Income
5.6210.3412.348.5512.1416.96
Other Non Operating Income (Expenses)
0.47-0.45-0.4-1.44-0.42-0.6
EBT Excluding Unusual Items
106.0434.99301.61195.97159.5377.77
Impairment of Goodwill
-11.63-11.63-13.17--23.06-22.42
Gain (Loss) on Sale of Assets
-0.080.010.120.040.1-0.29
Asset Writedown
-0.16-0.16-0.27-0.12-0.37-0.02
Other Unusual Items
0.52-1.164.70.4310.91-1.75
Pretax Income
94.6922.05292.99196.32147.153.28
Income Tax Expense
14.991.5639.8218.1220.189.46
Net Income
79.720.5253.18178.2126.9243.82
Net Income to Common
79.720.5253.18178.2126.9243.82
Net Income Growth
12.73%-91.91%42.07%40.41%189.66%-74.48%
Shares Outstanding (Basic)
438512460438401391
Shares Outstanding (Diluted)
438512460438401391
Shares Change (YoY)
-23.78%11.31%5.16%9.09%2.75%-2.52%
EPS (Basic)
0.180.040.550.410.320.11
EPS (Diluted)
0.180.040.550.410.320.11
EPS Growth
47.89%-92.73%35.10%28.71%181.91%-73.82%
Free Cash Flow
114.15-136.11112.51281.39147.2479.57
Free Cash Flow Per Share
0.26-0.270.240.640.370.20
Dividend Per Share
0.0500.0500.3570.3320.3320.332
Dividend Growth
-86.00%-86.00%7.69%---13.35%
Gross Margin
56.09%43.81%56.15%49.04%53.03%47.69%
Operating Margin
11.35%4.42%28.68%24.59%23.39%16.46%
Profit Margin
8.63%2.98%23.72%20.10%16.74%6.93%
Free Cash Flow Margin
12.35%-19.79%10.54%31.74%19.42%12.58%
EBITDA
172.4794.79366.14270.52228.63155.16
EBITDA Margin
18.67%13.78%34.31%30.51%30.16%24.52%
D&A For EBITDA
67.5564.3660.152.5251.3151.03
EBIT
104.9230.43306.04217.99177.33104.13
EBIT Margin
11.35%4.42%28.68%24.59%23.39%16.46%
Effective Tax Rate
15.83%7.06%13.59%9.23%13.72%17.76%
Revenue as Reported
924.04687.791,067886.57758.16632.7
Source: S&P Global Market Intelligence. Standard template. Financial Sources.